{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:04:09Z","timestamp":1773666249970,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.bbrc.2014.11.122","type":"journal-article","created":{"date-parts":[[2014,12,6]],"date-time":"2014-12-06T17:18:53Z","timestamp":1417886333000},"page":"860-865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Therapeutic potential of human adipose tissue-derived multi-lineage progenitor cells in liver fibrosis"],"prefix":"10.1016","volume":"456","author":[{"given":"Hanayuki","family":"Okura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Soeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuko","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Naba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiyoko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.11.122_b0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1365-2893.2003.00481.x","article-title":"Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death","volume":"11","author":"Kasahara","year":"2004","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.bbrc.2014.11.122_b0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2169\/internalmedicine.46.1784","volume":"6","author":"Saito","year":"2007","journal-title":"Intern. Med."},{"key":"10.1016\/j.bbrc.2014.11.122_b0015","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1097\/MCG.0000000000000162","volume":"8","author":"Manne","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.bbrc.2014.11.122_b0020","doi-asserted-by":"crossref","first-page":"C789","DOI":"10.1152\/ajpcell.00230.2013","volume":"305","author":"Mallat","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbrc.2014.11.122_b0025","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/01.TP.0000046533.93621.C7","article-title":"Living-donor liver transplantation: 12 years of experience in Asia","volume":"75","author":"Chen","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.bbrc.2014.11.122_b0030","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/lt.20642","article-title":"Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma","volume":"12","author":"Takada","year":"2006","journal-title":"Liver Transpl."},{"key":"10.1016\/j.bbrc.2014.11.122_b0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12262-012-0643-0","article-title":"Liver transplantation \u2013 an overview","volume":"75","author":"Rai","year":"2013","journal-title":"Indian J. Surg."},{"key":"10.1016\/j.bbrc.2014.11.122_b0040","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/ten.tec.2009.0208","volume":"16","author":"Okura","year":"2010","journal-title":"Tissue Eng. Part C Methods"},{"key":"10.1016\/j.bbrc.2014.11.122_b0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/ten.tec.2010.0139","volume":"17","author":"Okura","year":"2011","journal-title":"Tissue Eng. Part C Methods"},{"key":"10.1016\/j.bbrc.2014.11.122_b0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbrc.2011.07.035","article-title":"HMG-CoA reductase inhibitor augments the serum total cholesterol-lowering effect of human adipose tissue-derived multilineage progenitor cells in hyperlipidemic homozygous Watanabe rabbits","volume":"412","author":"Saga","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2014.11.122_b0055","first-page":"13","article-title":"The fetal livers as cell source for the regenerative medicine of liver and pancreas","volume":"1","author":"Semeraro","year":"2013","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bbrc.2014.11.122_b0060","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1038\/srep06494","article-title":"Cell-based therapy for acute and chronic liver failures: distinct diseases, different choices","volume":"4","author":"Sun","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2014.11.122_b0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2796.2012.02574.x","article-title":"Hepatocyte transplantation for inherited metabolic diseases of the liver","volume":"272","author":"Jorns","year":"2012","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbrc.2014.11.122_b0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2014.11.122_b0075","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1089\/scd.2011.0074","article-title":"Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis","volume":"20","author":"Saito","year":"2011","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.bbrc.2014.11.122_b0080","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1440-1746.2008.05381.x","article-title":"Autologous bone marrow cell infusion therapy for liver cirrhosis","volume":"3","author":"Sakaida","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2007","key":"10.1016\/j.bbrc.2014.11.122_b0085","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.clinbiochem.2007.04.017","article-title":"Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis, 2007","volume":"40","author":"Abdel Aziz","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbrc.2014.11.122_b0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3727\/096368909788237140","article-title":"Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow","volume":"18","author":"Hardjo","year":"2009","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bbrc.2014.11.122_b0095","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1634\/stemcells.2007-0941","article-title":"Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury","volume":"26","author":"Carvalho","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbrc.2014.11.122_b0100","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2337\/db09-0317","article-title":"Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9","volume":"58","author":"Ding","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2014.11.122_b0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/org.24279","article-title":"Adipose-derived stromal\/stem cells: a primer","volume":"9","author":"Gimble","year":"2013","journal-title":"Organogenesis"},{"key":"10.1016\/j.bbrc.2014.11.122_b0110","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/ten.tea.2009.0386","article-title":"Reduction of N-glycolylneuraminic acid xenoantigen on human adipose tissue-derived stromal cells\/mesenchymal stem cells leads to safer and more useful cell sources for various stem cell therapies","volume":"16","author":"Komoda","year":"2010","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.bbrc.2014.11.122_b0115","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/hep.20452","article-title":"Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice","volume":"40","author":"Sakaida","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2014.11.122_b0120","first-page":"7","article-title":"Advanced therapies using autologous bone marrow cells for chronic liver disease","volume":"14","author":"Takami","year":"2012","journal-title":"Discov. Med."},{"key":"10.1016\/j.bbrc.2014.11.122_b0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/713611034","article-title":"Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model","volume":"33","author":"Weber","year":"2003","journal-title":"Crit Rev Toxicol."},{"key":"10.1016\/j.bbrc.2014.11.122_b0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1872-034X.2011.00896.x","article-title":"Strategies to produce hepatocytes and hepatocyte-like cells from pluripotent stem cells","volume":"42","author":"Chistiakov","year":"2012","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbrc.2014.11.122_b0135","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/mrd.21223","article-title":"Induction of primordial germ cells from mouse induced pluripotent stem cells derived from adult hepatocytes","volume":"77","author":"Imamura","year":"2010","journal-title":"Mol. Reprod. Dev."},{"issue":"Suppl. 1","key":"10.1016\/j.bbrc.2014.11.122_b0140","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.ymgme.2010.01.011","article-title":"Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects","volume":"100","author":"Meyburg","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbrc.2014.11.122_b0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11095-007-9311-7","article-title":"Matrix metalloproteinase gene delivery for liver fibrosis","volume":"25","author":"Iimuro","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbrc.2014.11.122_b0150","doi-asserted-by":"crossref","first-page":"340257","DOI":"10.1155\/2014\/340257","article-title":"Management of fibrosis: the mesenchymal stromal cells breakthrough","volume":"2014","author":"Usunier","year":"2014","journal-title":"Stem Cells Int."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14021640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14021640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:10:58Z","timestamp":1757761858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14021640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0006291X14021640"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.11.122","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of human adipose tissue-derived multi-lineage progenitor cells in liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.11.122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}